Latest filing published 11 Jul 2024 for Alto Neuroscience, Inc., €17k.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adam Savitz is a declared insider of Alto Neuroscience, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 6 February 2024 to 10 July 2024.
On the market, this insider has only ever bought: 4 purchases, €430k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €80k and half below. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 4 purchases show a median change of -15.4%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
Most recently, on 11 July 2024, the filings show an open-market purchase worth €17k in Alto Neuroscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations